Metasphere Labs Inc.
LABZ
CNSX
| 04/30/2026 | 01/31/2026 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | -5.54% | -16.35% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 12.54% | -16.35% | |||
| Operating Income | -12.54% | 16.35% | |||
| Income Before Tax | -10.85% | 16.52% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -10.85% | 16.52% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -10.85% | 16.52% | |||
| EBIT | -12.54% | 16.35% | |||
| EBITDA | -- | -- | |||
| EPS Basic | 19.35% | 18.42% | |||
| Normalized Basic EPS | 20.51% | 17.02% | |||
| EPS Diluted | 19.35% | 18.42% | |||
| Normalized Diluted EPS | 20.51% | 17.02% | |||
| Average Basic Shares Outstanding | 37.94% | 2.79% | |||
| Average Diluted Shares Outstanding | 37.94% | 2.79% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||